Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 15/20 | 0.65 |
| ▸ | CNR1 | P21554 | 6/20 | 0.65 |
| ▸ | ALPL | P05186 | 2/20 | 0.40 |
| ▸ | FPR2 | P25090 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | TMPRSS4 | Q9NRS4 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1464633 | 0.82 | CNR2 (0.79) | CNR2CNR1ALPLMEN1POLB | |
| SCHEMBL1465784 | 0.82 | CNR2 (0.82) | CNR2CNR1ALPLPOLB | |
| SCHEMBL1464474 | 0.81 | CNR2 (1.00) | CNR2CNR1ALPLMEN1POLB | |
| SCHEMBL3961290 | 0.80 | CNR2 (0.55) | CNR2CNR1MEN1KMT2A | |
| SCHEMBL1465811 | 0.79 | CNR2 (0.75) | CNR2CNR1MEN1KMT2A | |
| SCHEMBL3962718 | 0.79 | CNR2 (0.63) | CNR2CNR1ALPLMEN1POLB | |
| SCHEMBL3962840 | 0.76 | CNR2 (0.42) | CNR2CNR1 | |
| SCHEMBL4080905 | 0.74 | CNR2 (0.64) | CNR2CNR1ALPLMEN1KMT2A | |
| SCHEMBL3964431 | 0.74 | CNR2 (0.61) | CNR2CNR1ALPLKMT2A | |
| SCHEMBL1464711 | 0.73 | CNR2 (0.83) | CNR2CNR1ALPLPOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2081905-A2 | SULFONYL COMPOUNDS WHICH MODULATE THE CB2 RECEPTOR | Boehringer Ingelheim International GmbH (DE) | 2009-07-29 | — | — | EP | disclosed |
| WO-2008014199-A2 | SULFONYL COMPOUNDS WHICH MODULATE THE CB2 RECEPTOR | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2008-01-31 | — | — | WO | disclosed |